Funds with similar focus
Fund Name | Location |
CapitaLand | Central, Central Region, Singapore |
Chasefield Capital | - |
Composite Capital Management | China, Hong Kong, Hong Kong Island |
Crescendo Equity Partners | Seoul, Seoul-t'ukpyolsi, South Korea |
Cresson Management | - |
Entrepia Ventures | California, Santa Clara, United States |
Forebright Capital | China, Guangdong, Shenzhen |
Four Seasons Ventures | District of Columbia, United States, Washington |
GF Capital Management & Advisors | New York, New York, United States |
GGM Capital | Canton Luxembourg, Luxembourg, Münsbach |
Jinhua Chaduan Touzi Guanli Co., Ltd. | China, Jinhua, Zhejiang |
JMP Securities | California, San Francisco, United States |
Kearny Venture Partners | California, San Francisco, United States |
Life Science Institute | Japan, Tokyo |
LiteCap | California, Los Gatos, United States |
Manbang Group | China, Guiyang, Guizhou |
Omron Corporation | Japan, Kyoto, Kyoto Prefecture |
Shanghai Ruizhang Investment | - |
Shenzhenshi Xiaohe Chuangye Touzi | China, Guangdong, Shenzhen |
WaterEquity | Kansas City, Missouri, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Nob Hill Therapeutics | $3M | 06 Aug 2024 | Albuquerque, New Mexico, United States | ||
Neurexis Therapeutics | 08 Apr 2020 | Aurora, Colorado, United States | |||
Solenic Medical | $610K | 01 Apr 2020 | College Station, Texas, United States | ||
Filtravate | 26 Feb 2020 | Las Cruces, New Mexico, United States | |||
Solenic Medical | $250K | 01 Mar 2019 | College Station, Texas, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Nob Hill Therapeutics | $3M | 06 Aug 2024 | Albuquerque, New Mexico, United States | ||
Neurexis Therapeutics | 08 Apr 2020 | Aurora, Colorado, United States | |||
Solenic Medical | $610K | 01 Apr 2020 | College Station, Texas, United States | ||
Filtravate | 26 Feb 2020 | Las Cruces, New Mexico, United States | |||
Solenic Medical | $250K | 01 Mar 2019 | College Station, Texas, United States |